has decided to embark on the path of fine-tuning and developing rhNGF in its formulation for clinical use, at its own biotech facility in L’Aquila. and in Naples, where there are the laboratories of Drug Discovery and Technology Formulation, within a long-term collaboration with CNR. Italian excellence: the Dompé Hub in L’Aquila. Dompé has concentrated its manufacturing and research and development activities at its L’Aquila hub.
|Published (Last):||12 February 2007|
|PDF File Size:||11.74 Mb|
|ePub File Size:||14.48 Mb|
|Price:||Free* [*Free Regsitration Required]|
The safety and efficacy of Oxervate, a topical eye drop containing cenegermin, was studied in a total of patients with neurotrophic keratitis in two, eight-week, randomized controlled multi-center, double-masked studies.
In the first study, only patients with the disease in one eye were enrolled, while in the second study, patients with the disease in both eyes were treated in both eyes bilaterally.
In his new role, Flavio Mantelli will also be responsible for managing the current and soon to be launched formulatkon trials on ophthalmology.
Post was not sent – check your email addresses! The BF unit works mainly in the field of ophthalmology with the aim of optimising the periocular and intraocular release of proteins, for the treatment of rare diseases.
Reparixin is the first low molecular weight blocker of CXCL8 biological activity in clinical development. This site uses third party cookies.
Flavio Mantelli, born in Rome inis the author of 40 international scientific publications and of numerous chapters in volumes about ophthalmology.
Projects using Artificial Intelligence techniques Neural Networks, Fuzzy Logic are also under way at the facility for analysing and optimizing certain production processes.
The native three-dimensional structure is fundamental in order to guarantee the correct biological activity of the mature NGF. In the downstream process the proNGF is first checked for its correct three-dimensional structure folding phase and then purified. The application of Smart Factory concepts in the pharma context, in fact, is accompanied by certain peculiarities linked to qualitative and regulatory aspects.
Therefore these two amino acid changes have no influence on the final active ingredient rhNGFwhich is identical to the naturally secreted human protein. At this point, the bacterial cells are separated from the cultivation broth, concentrated and recovered through a continuous centrifuge in order to separate the cells from the other residual organic material of the fermentation.
Primary packaging — in a controlled air environment — in which the pharmaceutical product is inserted into the individual stick, packet or container. You are going to leave this site.
New management for the Dompé Ophthalmology Division | Dompé
The protein—in this case Nerve Growth Factor, NGF —is produced using a formulxtion organism the bacterium Escherichia Coli of which the entire genome and the complex of biological interactions is known in detail. This study is aimed at assessing the safety and the efficacy of two dose regimens of recombinant human nerve growth factor rhNGF eye drops solution compared to vehicle for inducing a complete healing of stage 2 persistent epithelial defect and 3 corneal ulcer neurotrophic keratitis.
Inorphan drug designations in the E. The activity includes every stage of development, from refinement of the experimental design for creating the drug, to the identification of creative, innovative and flexible solutions that could lead to industrial production.
During the granulation phase the active ingredient and the excipients are bonded until they become granules, which, in turn, are finally coated in excipients in the complex phase of coating until the formulation defined for packaging is obtained.
This makes it possible to guarantee the high quality standards required by the pharmaceutical sector, which is heavily regulated. The pro-sequence is further cleaved during the production process by enzymatic hydrolysis.
NGF was the first neurotrophic factor to be identified and purified and over the last fifty years, its role in neuronal development and its biological activity on neural tissue has been of great interest to science. The site covers an area ofsquare metres. We suggest you to update it for free by following one of the these links, choosing the browser you prefer: The buildings formulatiob house the research laboratories, the production, the warehouse, the utilities, the general services and the administrative offices cover a total area of over 36, square metres.
This site uses third party cookies.
Our story | Dompé
Do you want to be redirected to the mobile version? The loss of corneal sensation impairs corneal health causing progressive damage to the top layer of the cornea, including corneal thinning, ulceration, and perforation in severe cases.
The most common adverse reactions in patients taking Oxervate are eye pain, ocular hyperemia enlarged blood vessels in the white of the eyeseye inflammation and increased lacrimation watery eyes. The production of liquids refers to the two lines of formulation and packaging known as small and large volume.
The current annual production capacity is 50 million packs. Do you want to be redirected to the mobile version? One group received Oxervate, a second group received an eye drop with a different concentration of cenegermin, and the third group received an eye drop without cenegermin. In this first phase fromulation gene doompe in the bacterium for the production of the protein is rendered silent.
We suggest you to update it for free by following one of the these links, choosing the browser you prefer: Do you want to be redirected to the mobile version? This site uses third party cookies.